8MV0 Stock Overview
Operates as a biotechnology company. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
BioHarvest Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$5.70 |
| 52 Week High | CA$7.00 |
| 52 Week Low | CA$3.60 |
| Beta | 1.49 |
| 11 Month Change | 29.84% |
| 3 Month Change | 20.63% |
| 1 Year Change | 58.11% |
| 33 Year Change | -38.78% |
| 5 Year Change | n/a |
| Change since IPO | 70.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| 8MV0 | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 7.1% | 1.7% | -0.02% |
| 1Y | 58.1% | -5.9% | 8.2% |
Return vs Industry: 8MV0 exceeded the German Personal Products industry which returned -7.6% over the past year.
Return vs Market: 8MV0 exceeded the German Market which returned 7.4% over the past year.
Price Volatility
| 8MV0 volatility | |
|---|---|
| 8MV0 Average Weekly Movement | 7.0% |
| Personal Products Industry Average Movement | 3.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 8MV0's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 8MV0's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ilan Sobel | www.bioharvest.com |
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells.
BioHarvest Sciences Inc. Fundamentals Summary
| 8MV0 fundamental statistics | |
|---|---|
| Market cap | €102.38m |
| Earnings (TTM) | -€15.59m |
| Revenue (TTM) | €18.37m |
5.6x
P/S Ratio-6.6x
P/E RatioIs 8MV0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 8MV0 income statement (TTM) | |
|---|---|
| Revenue | US$19.13m |
| Cost of Revenue | US$9.29m |
| Gross Profit | US$9.84m |
| Other Expenses | US$26.07m |
| Earnings | -US$16.23m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 25, 2024
| Earnings per share (EPS) | -0.94 |
| Gross Margin | 51.44% |
| Net Profit Margin | -84.84% |
| Debt/Equity Ratio | 17.4% |
How did 8MV0 perform over the long term?
See historical performance and comparison